Air Force Medical University, China
Profiles
Early Academic Pursuits
Dr. Zhao Wei began his academic journey in chemistry, completing undergraduate studies at Nankai University, where he was recognized for academic excellence. He pursued doctoral studies in Medicinal Chemistry at the Academy of Military Medical Sciences under the mentorship of esteemed academician Li Song. His doctoral work laid a strong foundation for his future contributions in the field of drug design and medicinal chemistry.
After completing his doctoral studies, Dr. Zhao commenced his professional academic career at the School of Pharmacy, Air Force Medical University. He joined the institution as a lecturer and has since advanced to the role of Associate Professor. Throughout his tenure, he has actively engaged in both undergraduate and postgraduate teaching, while simultaneously driving research efforts in drug discovery, particularly targeting neurological disorders.
Contributions and Research Focus
Dr. Zhao has made significant strides in the design, synthesis, and screening of small-molecule therapeutics. His core research areas include acetylcholinesterase (AChE) reactivators aimed at treating organophosphorus poisoning through novel non-quaternary reactivators with dual-site binding capabilities. Over 300 compounds have been synthesized, with more than 30 demonstrating in vitro reactivation potency and 2 showing promising in vivo efficacy. In the development of anti-Alzheimer’s agents, he synthesized over 100 quinoline-based AChE inhibitors, more than 20 of which showed potent enzyme inhibition. Some compounds demonstrated dual AChE/BChE activity, giving rise to the concept of Fragment-Informed Structure-Activity Relationship (SAR). In neuroprotective agent development, he synthesized over 100 dihydropyridine derivatives targeting ASICs and GPR30, identifying five highly active compounds with significant in vitro neuroprotective effects.
Impact and Influence
Dr. Zhao’s work addresses pressing global health challenges, such as neurodegenerative diseases and chemical poisoning. His innovative strategies for drug reactivation and multi-target inhibition have introduced new directions in medicinal chemistry. His success in translating fragment-based insights into potent therapeutic candidates highlights his influence in shaping modern drug design methodologies.
Academic Cites and Recognition
Dr. Zhao’s scholarly output has garnered attention in high-impact medicinal chemistry and pharmacology journals. His research papers are widely cited by academic peers, reflecting the importance and applicability of his findings across both theoretical and applied medicinal sciences.
Technical Skills and Methodological Strengths
He possesses deep expertise in organic synthesis, bioassays for neuropharmacological evaluation, and structure-based drug design. His ongoing work incorporates Fragment-Based Drug Design (FBDD), molecular docking, and SAR analysis, ensuring an integrative approach to rational drug development.
Teaching Experience and Mentorship
As a faculty member of the School of Pharmacy, Dr. Zhao has been instrumental in developing curriculum content for medicinal chemistry courses. He has supervised numerous undergraduate and graduate research projects, instilling analytical and experimental skills in the next generation of pharmaceutical scientists.
Professional Leadership
He serves as Vice Chairperson of the Pharmaceutical Chemistry Professional Committee under the Shaanxi Pharmaceutical Society, contributing to academic exchange, policy development, and advancement of pharmaceutical research within the region.
Legacy and Future Contributions
Dr. Zhao Wei continues to expand his research into innovative therapeutic strategies for nervous system disorders. His long-term vision includes the development of multifunctional drug candidates that integrate efficacy, safety, and novel mechanisms of action. With a commitment to excellence in both education and research, he is poised to leave a lasting legacy in the field of medicinal chemistry.
Notable Publications
Screening of efficient salicylaldoxime reactivators for DFP and paraoxon-inhibited acetylcholinesterase
Authors: Zhao Wei, Dongxu Zhang, Xueying Liu, Huifang Nie, Qin Ouyang, Xinlei Zhang, Zhibing Zheng
Journal: RSC Medicinal Chemistry
Year: 2024
Lifestyle habits and gastric cancer in an East Asian population: a Mendelian randomization study
Authors: Yuegui Tan, Zhao Wei, Kun Liu, Yuzhen Qin, Wenqi Hui, Zhao Wei
Journal: Frontiers in Oncology
Year: 2023
Discovery of Novel Non-Oxime Reactivators Showing In Vivo Antidotal Efficiency for Sarin Poisoned Mice
Authors: Zhao Wei, Xinlei Zhang, Huifang Nie, Lin Yao, Yanqin Liu, Zhibing Zheng, Qin Ouyang
Journal: Molecules
Year: 2022
Drug Synthesis and Analysis of an Acetylcholinesterase Inhibitor: A Comprehensive Medicinal Chemistry Experience for Undergraduates
Authors: Yang J., Yuan Y., Gu J., Li A., Wei Z., Ouyang Q.
Journal: Journal of Chemical Education
Year: 2021